Intrathecal bupivacaine with morphine versus bupivacaine with buprenorphine for spinal anesthesia for cancer cervix
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2024/03/064527
- Lead Sponsor
- SHREE KRISHNA HOSPITAL BHAIKAKA UNIVERSITY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the patients undergoing Brachytherapy for cervical cancer
Exclusion Criteria
1. Patients refusing in take part in the study. 2. 2. Patients who are allergic to amide local anaesthetic drugs
3. Patients who have contraindication for spinal anaesthesia such asinfection at the site of injection, bleeding or coagulation abnormality, increased intracranial pressure , spinal deformities.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method time when patient has ambulation and demands rescue analgesiaTimepoint: 0 min, 15 min, 30 min, 45 min, 60 min, then every 30 min till 720 min
- Secondary Outcome Measures
Name Time Method To study the effects of intrathecal Buprenorphine on <br/ ><br>intraoperative hemodynamics, side effects (Bradycardia, hypotension, respiratory <br/ ><br>depressions, pruritus, nausea, vomitingTimepoint: 0 min, 15 min, 30 min, 45 min, 60 min, then every 30 min till 720 min